Ataraxa LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Jan 30, 2025, the fund has sold $1,035,000 of interests to 8 investors since its first sale in Jan 2025. The minimum investment it accepts from an outside investor is $10,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Ataraxa GP LLC; Avenir Management Company, LLC; Andrew Sugrue.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $1,035,000Cumulative sales reported on Form D
- Investors
- 8
- First sale
- Jan 15, 2025
- Minimum investment
- $10,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Ataraxa GP LLC; Avenir Management Company, LLC; Andrew Sugrue
- Latest Form D
- Jan 30, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Ataraxa LP
What is the minimum investment for Ataraxa LP?
According to its latest Form D, filed Jan 30, 2025, the minimum investment Ataraxa LP accepts from an outside investor is $10,000.
Who can invest in Ataraxa LP?
Ataraxa LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Ataraxa LP raised?
Ataraxa LP reports $1,035,000 sold from 8 investors on its Form D filed Jan 30, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Ataraxa LP based?
Ataraxa LP is based in New York, New York.
When did Ataraxa LP launch?
Ataraxa LP reports its first sale in Jan 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 12% of the 2,545 hedge funds based in New York, and more than 6% of all 10,309 that report sales.